Migraine Canada Logo
MIGRAINE MODE
How Many People Have Headaches?

How Many People Have Headaches?

Headaches are a widespread symptom with over 200 potential causes, ranging from visible conditions like brain tumours to common, invisible ones such as migraine and tension-type headache (TTH). While TTH is more prevalent, migraine is significantly more disabling....
What Your Employer Should Know About Migraine

What Your Employer Should Know About Migraine

Does your employer understand the impact of migraine? From its prevalence to its disabling effects, migraine is not just a headache—it affects productivity and quality of life. In this article, we discuss the common misconceptions surrounding migraine, the impact on...
CEFALY: Transcutaneous Stimulation for Migraine

CEFALY: Transcutaneous Stimulation for Migraine

Discover how the CEFALY device offers relief from migraine through transcutaneous stimulation. Approved for both acute and preventative treatment of migraine, CEFALY targets the trigeminal nerve to modulate pain processing. Explore its advantages, research findings,...
Magnets for Migraine: Transcranial Magnetic Stimulation

Magnets for Migraine: Transcranial Magnetic Stimulation

Modulating the electrical activity of the brain can be achieved with neuromodulation devices. One such therapy is the single pulse transcranial magnetic stimulator (sTMS), approved in the USA for both acute and preventive treatment of migraine in adults. Explore how...
CGRP Monoclonal Antibodies (MABs): Access and Coverage

CGRP Monoclonal Antibodies (MABs): Access and Coverage

Understanding the access and coverage for CGRP monoclonal antibodies (MABs) is essential for managing the costs associated with these medications. Below is an overview of the current landscape, including insurance coverage, patient support programs, and considerations...